Qualigen Therapeutics (FRA:7R90) FCF Yield % : -376.25 (As of Apr. 02, 2025)

View and export this data going back to 2020. Start your Free Trial

What is Qualigen Therapeutics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Qualigen Therapeutics's Trailing 12-Month Free Cash Flow is €-8.91 Mil, and Market Cap is €2.38 Mil. Therefore, Qualigen Therapeutics's FCF Yield % for today is -376.25%.

The historical rank and industry rank for Qualigen Therapeutics's FCF Yield % or its related term are showing as below:

FRA:7R90' s FCF Yield % Range Over the Past 10 Years
Min: -4115.34 Med: -169.12 Max: -5.14
Current: -376.25

During the past 4 years, the highest FCF Yield % of Qualigen Therapeutics was -5.14%. The lowest was -4115.34%. And the median was -169.12%.

FRA:7R90's FCF Yield % is ranked worse than
94.93% of 1498 companies
in the Biotechnology industry
Industry Median: -15.56 vs FRA:7R90: -376.25

Qualigen Therapeutics's FCF Margin % for the quarter that ended in Sep. 2024 was 0.00%.

Qualigen Therapeutics FCF Yield % Historical Data

The historical data trend for Qualigen Therapeutics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qualigen Therapeutics FCF Yield % Chart

Qualigen Therapeutics Annual Data

Trend

Mar20

Dec21

Dec22

Dec23

FCF Yield %

-39.03

-275.70

-384.37

Qualigen Therapeutics Quarterly Data
	Sep19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
FCF Yield %	Get a 7-Day Free Trial															77.69	-846.27	-123.25	-449.48	-205.90

Competitive Comparison of Qualigen Therapeutics's FCF Yield %

For the Biotechnology subindustry, Qualigen Therapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Qualigen Therapeutics's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Qualigen Therapeutics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Qualigen Therapeutics's FCF Yield % falls into.

Save Embed

;

Save Embed

;

Qualigen Therapeutics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Qualigen Therapeutics's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-9.449	/	2.458325
	=	-384.37%

Qualigen Therapeutics's annualized FCF Yield % for the quarter that ended in Sep. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-1.622	*	4	/	3.151
	=	-205.90%

Qualigen Therapeutics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Qualigen Therapeutics FCF Yield % Related Terms

Thank you for viewing the detailed overview of Qualigen Therapeutics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Qualigen Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Qualigen Therapeutics Inc (FRA:7R90) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

QLGN:USA

Address

5857 Owens Avenue, Suite 300, Carlsbad, CA, USA, 92008

Website

https://www.qlgntx.com

Qualigen Therapeutics Inc is a early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's lead program, QN-302, is an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells.

Qualigen Therapeutics Headlines

No Headlines